News
Competition Expert Dr. Kevin Pflum Joins The Brattle Group as Principal
4+ hour, 14+ min ago (283+ words) Jul 09, 2026, 10: 45 ET Much of Dr. Pflum's work has focused on competition issues in the healthcare and life sciences sectors, including high-profile merger reviews, monopolization claims, and government enforcement actions. He has been retained by plaintiffs and defendants in antitrust litigation,…...
How AI Is Changing Drug Discovery and What It Will Take to Unlock Its Full Potential
38+ min ago (339+ words) It can take more than a decade to bring a new medicine to patients. That timeline has pushed researchers to look for new ways to work faster and learn more from data. AI is now a growing part of that…...
Fragrance firms say hybrid relationships not per se unlawful under US antitrust law | MLex | Specialist news and analysis on legal risk and regulation
1+ hour, 17+ min ago (177+ words) Fragrance firms say hybrid relationships not per se unlawful under US antitrust law MLex Law360 | The Practice of Law Law360 Authority | Deep News & Analysis Law360 Pulse | The Business of Law Fragrance firms say hybrid relationships not per se unlawful under US antitrust law…...
Autolomous and Cellular Origins integrate platforms to deliver end-to-end cell therapy manufacturing
3+ hour, 43+ min ago (258+ words) Autolomous and Cellular Origins have announced the integration of their respective autolo MATE and Constellation platforms, bringing full automation and digitisation to the entire cell therapy manufacturing process. The pair said in a statement that the new scalable approach would…...
Daniel Dizon: From Synthetix Engineer to Swell CEO
1+ hour, 5+ min ago (706+ words) Daniel Dizon is an Australian blockchain entrepreneur and tech investor based in Sydney. He holds a Bachelor's degree in Information Systems from Swinburne University of Technology. Dizon's move into crypto started hands-on. He worked as a solidity engineer at Synthetix…...
From China's First Approved Stem Cell Therapy to Its First Exosome IND: Cyto Niche Enables Dual Industry Firsts
4+ hour, 24+ min ago (177+ words) Cyto Niche Biotech Pte. Ltd. 3 D Flo Trix" viva EXO Exosome Harvesting System 3 D Flo Trix" viva SPIN-SU Single-Use Cell Culture System The clearance of STX11101 shatters this industrial bottleneck, proving that high-purity, reproducible exosome therapeutics can be manufactured at a…...
IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform That Reduced Alzheimer's Data Harmonization Time by 90% in Representative Workflow
5+ hour, 55+ min ago (124+ words) The Daily Corinthian Seven presentations highlight patent-pending agentic automation, speech-based cognitive models, EHR mining, and predictive analytics designed to support Alzheimer's discovery and clinical development POTOMAC, MD / ACCESS Newswire / July 9, 2026 / IGC Pharma, Inc. (NYSE American: IGC) ("IGC" or the "Company…...
Oxylabs Reaches $3. 6 B Value After Agreeing to Its First Outside Investment
2+ hour, 5+ min ago (1106+ words) Proxies & Advanced Proxy Solutions 175 M+ ethically sourced IPs built for the highest reliability. Premium static residential proxies from trusted ASNs for most difficult targets. Dedicated IPs from premium ASNs for demanding scraping. 20 M+ IP addresses from real mobile devices for…...
Rewriting the Economics of Drug Discovery with Ben Taylor
2+ hour, 29+ min ago (1613+ words) 09 Jul 2026, 23: 50 In many ways, the human body is an undiscovered country." But this lack of knowledge, in turn, represents an opportunity " one that firms such as Recursion are hoping to unlock with artificial intelligence (AI). This represents a new model…...
GSK ends brain drug alliance with Alector
3+ hour, 6+ min ago (190+ words) Clinical setbacks derailed what was once a potentially $2. 2 billion deal that marked GSK's return to neuroscience. A collaboration between GSK and the California-based biotechnology company Alector has fizzled following major setbacks for the experimental brain drugs at the center of…...